Cyclophosphamide
Conditioning
First Affiliated Hospital Xi'an Jiaotong UniversitySmall moleculePhase 2/3Active
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
14 Active assets in the Conditioning cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine First Affiliated Hospital of Zhejiang University | Phase 3 | BB |
Evomela First Affiliated Hospital of Zhejiang University | Phase 3 | BB |
Busulphan First Affiliated Hospital Xi'an Jiaotong University | Phase 2/3 | B |
Idarubicine Nanfang Hospital, Southern Medical University | Phase 2/3 | B |
Venetoclax First Affiliated Hospital of Zhejiang University | Phase 3 | B |
View all 15 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →